Literature DB >> 12534918

Usefulness of diagnostic imaging in primary hyperparathyroidism.

Kazuya Sekiyama1, Koichiro Akakura, Kazuo Mikami, Ken-Ichi Mizoguchi, Toyofusa Tobe, Koichi Nakano, Tsutomu Numata, Akiyoshi Konno, Haruo Ito.   

Abstract

BACKGROUND: In patients with primary hyperparathyroidism, prevention of urinary stone recurrence can be achieved by surgical removal of the enlarged parathyroid gland. To ensure the efficacy of surgery for primary hyperparathyroidism, preoperative localization of the enlarged gland is important. In the present study, usefulness of diagnostic imaging for localization of the enlarged gland was investigated in primary hyperparathyroidism.
METHODS: We retrospectively examined the findings of imaging studies and clinical records in 79 patients (97 glands) who underwent surgical treatment for primary hyperparathyroidism at Chiba University Hospital between 1976 and 2000. The detection rates of accurate localization were investigated for imaging techniques, such as ultrasonography (US), computed tomography (CT), magnetic resonance imaging (MRI), thallium-201 and technetium-99m pertechnetate (Tl-Tc) subtraction scintigraphy and 99mTc-methoxyisobutylisonitrile (MIBI) scintigraphy, and analysed in relation to the size and weight of the gland and pathological diagnosis.
RESULTS: The detection rates by US, CT, MRI, Tl-Tc subtraction scintigraphy and MIBI scintigraphy were 70%, 67%, 73%, 38% and 78%, respectively. The overall detection rate changed from 50% to 88% before and after 1987. The detection rate of MIBI scintigraphy was superior to Tl-Tc subtraction scintigraphy.
CONCLUSION: In primary hyperparathyroidism, improvement of accurate localization of an enlarged parathyroid gland was demonstrated along with recent advances in imaging techniques including MIBI scintigraphy.

Entities:  

Mesh:

Year:  2003        PMID: 12534918     DOI: 10.1046/j.1442-2042.2003.00564.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  7 in total

Review 1.  How to localize parathyroid tumors in primary hyperparathyroidism?

Authors:  T Uruno; E Kebebew
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidism.

Authors:  S Mazzeo; C Cappelli; D Caramella; A Belcari; F Forasassi; V Battaglia; A Giannini; R Pasquariello; S Pallocci; G Caproni; C Marcocci; A Pinchera; P Miccoli; C Bartolozzi
Journal:  Radiol Med       Date:  2007-07-23       Impact factor: 3.469

3.  11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.

Authors:  Domenico Rubello; Stefano Fanti; Cristina Nanni; Mohsen Farsad; Paolo Castellucci; Stefano Boschi; Roberto Franchi; Giuliano Mariani; Lorraine M Fig; Milton D Gross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-25       Impact factor: 9.236

4.  Parathyroid disorder and concomitant thyroid cancer in patients with multiple endocrine neoplasia type 1: A retrospective cohort study.

Authors:  Ying Wang; Sheng Cai; He Liu; Rui-Na Zhao; Xing-Jian Lai; Ke Lv; Yu-Xin Jiang; Jian-Chu Li
Journal:  Medicine (Baltimore)       Date:  2021-09-10       Impact factor: 1.817

5.  [Primary hyperparathyroidism: parathyroid scintigraphy and ultrasound in problem patients].

Authors:  E Van De Flierdt; A Dropmann; J Böck; F Spelsberg; H Fürst
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

6.  Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration.

Authors:  Hiroyuki Tamiya; Megumi Miyakawa; Akira Takeshita; Daishu Miura; Yasuhiro Takeuchi
Journal:  J Bone Miner Metab       Date:  2014-09-17       Impact factor: 2.626

7.  Role of cervical ultrasonography in primary hyperparathyroidism.

Authors:  Feroze Shaheen; Nisar Chowdry; Tariq Gojwari; Arshad Iqbal Wani; Showkat Khan
Journal:  Indian J Radiol Imaging       Date:  2008-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.